Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus
NCT06820060 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2026-03-10
Summary
Performance evaluation of QIAstat-Dx® ME Panel Plus using the QIAstat-Dx® Analyzer to demonstrate that the QIAstat-Dx® ME Panel Plus achieves its intended performance during normal conditions of use by the intended user in the intended environment
Conditions
- Meningitis
- Encephalitis Infection
Sponsors & Collaborators
-
QIAGEN Gaithersburg, Inc
lead INDUSTRY
Principal Investigators
-
Sarah Johnson · Qiagen Manchester Limited
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-03
- Primary Completion
- 2026-01-15
- Completion
- 2026-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis
NCT00942006 ·Status: UNKNOWN ·Phase: NA
-
Study of Lyme Neuroborreliosis
NCT01635530 ·Status: COMPLETED ·Phase: PHASE4
-
Searching for Persistence of Infection in Lyme Disease
NCT01143558 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phase 1/2 Lyme Vaccine Study
NCT01504347 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
NCT05975099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Aseptic Meningoencephalitis in Slovenia
NCT02328469 ·Status: UNKNOWN
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT00001539 ·Status: RECRUITING
-
Biomarker Study of Previously Treated Lyme Disease Volunteers in Comparison to Healthy Volunteers
NCT04835792 ·Status: UNKNOWN
-
Study on Early Lyme Neuroborreliosis
NCT00910533 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France
NCT07343089 ·Status: RECRUITING
-
Ceftriaxone for Post-Treatment Lyme Disease
NCT06785402 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis
NCT02553473 ·Status: COMPLETED ·Phase: PHASE3
-
64Cu-DOTATATE-PET for Lyme Neuroborreliosis
NCT06392815 ·Status: RECRUITING ·Phase: NA
-
Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
NCT00138801 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
NCT07226882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Next Generation Sequencing Detection of Lyme Disease
NCT03505879 ·Status: COMPLETED
-
Xenodiagnosis After Antibiotic Treatment for Lyme Disease
NCT02446626 ·Status: COMPLETED ·Phase: NA
-
Direct Diagnosis of Disseminated Lyme Borreliosis.
NCT04719962 ·Status: UNKNOWN ·Phase: NA
-
Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.
NCT07230028 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosis
NCT01205464 ·Status: COMPLETED ·Phase: NA
-
PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics
NCT04577053 ·Status: TERMINATED ·Phase: NA
-
Performance Evaluation of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis
NCT03873974 ·Status: COMPLETED
-
Duration of Doxycycline Treatment in MEM Patients
NCT03337932 ·Status: RECRUITING ·Phase: NA
-
Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years
NCT00161785 ·Status: COMPLETED ·Phase: PHASE4
-
Doxycycline in Therapy of Erythema Migrans
NCT01475708 ·Status: COMPLETED